Extended Valganciclovir Prophylaxis in D+/R− Kidney Transplant Recipients is Associated With Long-Term Reduction in Cytomegalovirus Disease: Two-Year Results of the IMPACT Study-Reference-Cited by-同舟云学术

Extended Valganciclovir Prophylaxis in D+/R− Kidney Transplant Recipients is Associated With Long-Term Reduction in Cytomegalovirus Disease: Two-Year Results of the IMPACT Study

Published:2010-12-27 Issue:12 Volume:90 Page:1427-1431
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Humar Atul,Limaye Ajit P.,Blumberg Emily A.,Hauser Ingeborg A.,Vincenti Flavio,Jardine Alan G.,Abramowicz Daniel,Ives Jane A. L.,Farhan Mahdi,Peeters Patrick

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference24 articles.

1. Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: A collaborative transplant study report.;Opelz;Am J Transplant,2004

2. Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report.;Preiksaitis;Am J Transplant,2005

3. Transplant infections [ed. 2].;Paya,2003

4. The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: The end of the ‘silo hypothesis.’;Rubin;Curr Opin Infect Dis,2007

5. Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection.;Kranz;Pediatr Transpalnt,2008

Cited by 182 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update;Transplantation Reviews;2024-12

2. Cytomegalovirus surveillance after antiviral prophylaxis in CMV mismatched transplant patients: Does recurrent cytomegalovirus DNAemia impact patient survival?;Transplant Infectious Disease;2024-05-10

3. Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant Recipients;Transplant International;2024-05-09

4. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients;Cochrane Database of Systematic Reviews;2024-05-03

5. Prevention and management of cytomegalovirus infection and disease in kidney transplant: A consensus statement of the Transplantation Society of Taiwan;Journal of the Formosan Medical Association;2024-05